BriaCell Therapeutics Corp.
BCTXNasdaqCIK 1610820HealthcareFiscal year ends Jul 31
Reports and events: 149 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-06-1416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-023860 |
| 2024-05-2408:58 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-021272 |
| 2024-05-1716:51 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020460 |
| 2024-04-0216:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-012774 |
| 2024-03-1817:15 ET | 10-Q | Quarterly reportPeriod 2024-01-31 | 0001493152-24-010354 |
| 2024-01-3117:24 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-004525 |
| 2024-01-0916:05 ET | DEF 14A | Proxy statementPeriod 2024-01-09 | 0001493152-24-001830 |
| 2023-12-2016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045569 |
| 2023-12-1417:00 ET | 10-Q | Quarterly reportPeriod 2023-10-31 | 0001493152-23-044892 |
| 2023-12-1417:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-044891 |
| 2023-11-3007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043142 |
| 2023-11-0308:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-039228 |
| 2023-10-2517:26 ET | 10-K | Annual reportPeriod 2023-07-31 | 0001493152-23-038298 |
| 2023-10-2517:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-038297 |
| 2023-09-0808:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-032041 |
| 2023-09-0716:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-031982 |
| 2023-08-3117:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-031061 |
| 2023-08-3117:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-031359 |
| 2023-08-2516:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-030245 |
| 2023-08-2116:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-029604 |
| 2023-07-2616:05 ET | DEF 14A | Proxy statementPeriod 2023-07-26 | 0001493152-23-025573 |
| 2023-06-2709:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-022575 |
| 2023-06-1417:18 ET | 10-Q | Quarterly reportPeriod 2023-04-30 | 0001493152-23-021287 |
| 2023-05-3116:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-019652 |
| 2023-05-2211:48 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-018481 |
| 2023-05-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-017363 |
| 2023-04-1716:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-012566 |
| 2023-03-3017:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-009816 |
| 2023-03-1618:00 ET | 10-Q | Quarterly reportPeriod 2023-01-31 | 0001493152-23-007796 |
| 2023-02-2308:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-005827 |
| 2023-02-1516:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-005199 |
| 2023-02-1016:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-004295 |
| 2023-01-2417:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-002354 |
| 2023-01-2316:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-002198 |
| 2023-01-1809:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-001731 |
| 2023-01-1706:01 ET | DEF 14A | Proxy statementPeriod 2023-01-17 | 0001493152-23-001505 |
| 2023-01-1011:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-001049 |
| 2022-12-1416:44 ET | 10-Q | Quarterly reportPeriod 2022-10-31 | 0001493152-22-035452 |
| 2022-12-0809:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-034831 |
| 2022-11-3016:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-034020 |
| 2022-11-1009:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-031250 |
| 2022-10-2818:00 ET | 10-K | Annual reportPeriod 2022-07-31 | 0001493152-22-029742 |
| 2022-10-2818:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-029741 |
| 2022-10-2109:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-029278 |
| 2022-09-1416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-025861 |
| 2022-08-0417:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-021361 |
| 2022-07-1807:27 ET | 6-K | Report of a foreign private issuerPeriod 2022-07-18 | 0001493152-22-019531 |
| 2022-07-0509:05 ET | 6-K | Report of a foreign private issuerPeriod 2022-07-05 | 0001493152-22-018457 |
| 2022-06-2916:05 ET | 6-K | Report of a foreign private issuerPeriod 2022-06-29 | 0001493152-22-018099 |
| 2022-06-2416:05 ET | 6-K | Report of a foreign private issuerPeriod 2022-06-24 | 0001493152-22-017706 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.